G1 Therapeutics Inc (GTHX)
7.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 18, 16:00
G1 Therapeutics Total Assets (Quarterly): 98.69M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 98.69M |
| March 31, 2024 | 102.03M |
| December 31, 2023 | 121.54M |
| September 30, 2023 | 133.10M |
| June 30, 2023 | 147.89M |
| March 31, 2023 | 161.96M |
| December 31, 2022 | 187.96M |
| September 30, 2022 | 166.57M |
| June 30, 2022 | 186.88M |
| March 31, 2022 | 218.24M |
| December 31, 2021 | 254.09M |
| September 30, 2021 | 243.50M |
| June 30, 2021 | 276.76M |
| March 31, 2021 | 308.56M |
| December 31, 2020 | 228.55M |
| September 30, 2020 | 258.23M |
| Date | Value |
|---|---|
| June 30, 2020 | 253.60M |
| March 31, 2020 | 256.51M |
| December 31, 2019 | 284.83M |
| September 30, 2019 | 317.19M |
| June 30, 2019 | 331.65M |
| March 31, 2019 | 351.68M |
| December 31, 2018 | 371.27M |
| September 30, 2018 | 393.02M |
| June 30, 2018 | 190.60M |
| March 31, 2018 | 195.74M |
| December 31, 2017 | 105.17M |
| September 30, 2017 | 119.55M |
| June 30, 2017 | 134.10M |
| March 31, 2017 | 39.29M |
| December 31, 2016 | 48.21M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
98.69M
Minimum
Jun 2024
308.56M
Maximum
Mar 2021
204.71M
Average
218.24M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| PetIQ Inc | 894.39M |
| Biomarin Pharmaceutical Inc | 6.851B |
| Regeneron Pharmaceuticals Inc | 37.44B |
| Verrica Pharmaceuticals Inc | 32.93M |
| Terns Pharmaceuticals Inc | 230.88M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 74.10M |
| Shareholders Equity (Quarterly) | 24.59M |
| Debt to Equity Ratio | 1.802 |
| Current Ratio | 2.478 |
| Net Debt Paydown Yield | 5.52% |